Disease | aspergillosis |
Comorbidity | C0376545|hematologic malignancies |
Sentences | 7 |
PubMedID- 19801584 | Contribution of galactomannan antigen detection in bal to the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies. |
PubMedID- 21281234 | Design issues in a randomized controlled trial of a pre-emptive versus empiric antifungal strategy for invasive aspergillosis in patients with high-risk hematologic malignancies. |
PubMedID- 20502511 | Current clinical evidence for the use of aerosolized delivery is limited to amphotericin b products for prophylaxis against invasive pulmonary aspergillosis in patients with hematologic malignancies or lung transplantation. |
PubMedID- 21087680 | Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipients. |
PubMedID- 25018923 | Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin b alone or in combination with caspofungin. |
PubMedID- 22712456 | Initial voriconazole trough blood levels and clinical outcomes of invasive aspergillosis in patients with hematologic malignancies. |
PubMedID- 21791468 | Invasive aspergillosis in patients with hematologic malignancies: incidence and description of 127 cases enrolled in a single institution prospective survey from 2004 to 2009. |
Page: 1